Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Hypertension. 2019 Nov 4;74(6):1373–1382. doi: 10.1161/HYPERTENSIONAHA.119.13496

Table 2:

Associations of PWV measures, derived CAVI, and derived CFVI with the risk of cardiovascular events

Characteristics Q1 Q2 Q3 Q4

HR (95% CI) P* HR (95% CI) P* HR (95% CI) P*
Central arterial stiffness
cfPWV Model 1 1.66 (0.96, 2.84) 0.07 ref 2.20 (1.31, 3.69) 0.003 2.54 (1.53, 4.21) <0.001
Model 2 1.80 (1.05, 3.10) 0.03 ref 2.01 (1.20, 3.39) 0.01 2.05 (1.23, 3.43) 0.01
Model 3 2.03 (1.17, 3.50) 0.01 ref 2.02 (1.20, 3.41) 0.01 1.91 (1.13, 3.23) 0.02
Model 4 1.97 (1.14, 3.39) 0.02 ref 1.96 (1.16, 3.31) 0.01 1.83 (1.08, 3.09) 0.02

hfPWV Model 1 1.16 (0.71, 1.88) 0.56 ref 1.21 (0.75, 1.97) 0.44 1.74 (1.11, 2.73) 0.02
Model 2 1.28 (0.78, 2.08) 0.33 ref 1.09 (0.67, 1.78) 0.72 1.37 (0.86, 2.18) 0.19
Model 3 1.33 (0.81, 2.17) 0.26 ref 1.04 (0.63, 1.69) 0.89 1.26 (0.78, 2.03) 0.35
Model 4 1.33 (0.81, 2.17) 0.26 ref 1.04 (0.64, 1.70) 0.87 1.19 (0.73, 1.93) 0.48

Derived CFVI Model 1 1.38 (0.83, 2.28) 0.21 ref 1.49 (0.91, 2.46) 0.12 1.97 (1.23, 3.17) 0.01
Model 2 1.46 (0.88, 2.41) 0.15 ref 1.29 (0.78, 2.13) 0.32 1.47 (0.90, 2.40) 0.13
Model 3 1.51 (0.91, 2.50) 0.11 ref 1.25 (0.75, 2.07) 0.39 1.36 (0.83, 2.24) 0.22
Model 4 1.51 (0.91, 2.51) 0.11 ref 1.24 (0.75, 2.06) 0.39 1.30 (0.79, 2.14) 0.30

Composite arterial stiffness
baPWV Model 1 0.89 (0.54, 1.45) 0.63 ref 1.51 (0.98, 2.34) 0.06 1.45 (0.93, 2.25) 0.10
Model 2 1.02 (0.62, 1.67) 0.94 ref 1.40 (0.90, 2.17) 0.13 1.21 (0.77, 1.90) 0.40
Model 3 1.10 (0.67, 1.82) 0.70 ref 1.34 (0.86, 2.08) 0.19 1.13 (0.71, 1.81) 0.59
Model 4 1.09 (0.66, 1.80) 0.73 ref 1.35 (0.87, 2.09) 0.18 1.12 (0.70, 1.78) 0.64

haPWV Model 1 1.09 (0.67, 1.77) 0.73 ref 1.16 (0.72, 1.87) 0.55 1.52 (0.96, 2.40) 0.07
Model 2 1.21 (0.75, 1.98) 0.44 ref 1.07 (0.66, 1.73) 0.79 1.21 (0.76, 1.92) 0.43
Model 3 1.28 (0.78, 2.09) 0.33 ref 1.03 (0.63, 1.67) 0.91 1.14 (0.70, 1.85) 0.61
Model 4 1.28 (0.78, 2.09) 0.33 ref 1.00 (0.62, 1.63) 0.99 1.10 (0.67, 1.80) 0.70

Derived CAVI Model 1 1.07 (0.66, 1.74) 0.77 ref 1.30 (0.82, 2.07) 0.26 1.38 (0.87, 2.18) 0.17
Model 2 1.12 (0.69, 1.81) 0.66 ref 1.10 (0.69, 1.75) 0.69 0.97 (0.60, 1.56) 0.89
Model 3 1.13 (0.69, 1.84) 0.62 ref 1.08 (0.67, 1.72) 0.76 0.95 (0.59, 1.54) 0.84
Model 4 1.12 (0.68, 1.82) 0.66 ref 1.07 (0.67, 1.72) 0.76 0.94 (0.58, 1.52) 0.80

Model 1: Crude

Model 2: Age, sex, race

Model 3: Model 2 + education, current smoking, body mass index, history of diabetes, mean arterial pressure, antihypertensive medication, total cholesterol, high-density lipoprotein

Model 4: Model 3 + ankle brachial index, estimated glomerular filtration rate, albumin-creatinine ratio

HR=hazard ratio; Q1, Q2, Q3, Q4=quartile 1, quartile 2, quartile 3, quartile 4

*

P-values test quartile-specific estimates vs. the referent (quartile 2)